| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.84 | 0.0003 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0005 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |